Atrimed Pharmaceuticals

Atrimed Pharmaceuticals is an Indian biotechnology and pharmaceutical company specializing in the integration of plant science with modern medicine (phytology). Founded in 2003 and based in Bengaluru, the company leverages computer-aided drug design, bioinformatics, and artificial intelligence to screen and develop therapeutic plant-derived molecules. Atrimed has built one of the world's largest libraries of isolated phytochemicals, containing over 400,000 plant molecules. The company's product portfolio includes clinically validated Ayurvedic formulations, dermatological creams, and therapeutic nutrition targeting conditions such as psoriasis, eczema, acne, arthritis, and viral infections. Notably, Atrimed has advanced plant-based candidates like ATRICOV 452 through Phase 1 and Phase 2 clinical trials for the treatment of COVID-19.